Cardlytics, Inc.
CDLX Nasdaq Services-Computer Programming, Data Processing, Etc. Financials FY2016โFY2025
Last close ยท Oct 23, 2026
$1.80
3.7%What Cardlytics, Inc. does
No business description yet.
- Legal name
- Cardlytics, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K ยท Mar 4, 2026
- Accession ยท CIK
- 0001666071-26-000010
0001666071
Revenue and margins
Cardlytics, Inc. had $233M of revenue in fiscal 2025, down 16.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $8.8M in fiscal 2025, 3.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Cardlytics, Inc. returned โ to shareholders in fiscal 2025. The diluted share count rose 9.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably Cardlytics, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $233M | $122M | $91.8M | $65.6M | $48.7M |
| Debt incl. finance leases | $184M | $226M | $258M | $259M | $209M |
| Debt / equity | 0.3x | 1.1x | 1.9x | 3.7x | โ |
| Interest coverage | โ9.7x | โ114.4x | โ21.9x | โ22.0x | โ |
| Current ratio | 1.1x | 1.0x | 1.3x | 1.2x | 1.8x |
| Quick ratio | 1.1x | 1.0x | 1.3x | 1.2x | 1.8x |
| Total assets | $1.3B | $691M | $574M | $393M | $286M |
| Total liabilities | $573M | $480M | $439M | $323M | $292M |
| Shareholders' equity | $691M | $212M | $135M | $70.0M | โ$6.5M |
| Net debt (โ = net cash) | โ$49.1M | $104M | $166M | $194M | $160M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 4 | 3 / 8 | 5 / 8 | 2 / 8 | 3 / 8 | 2 / 8 | 4 / 8 | 2 / 8 | 5 / 8 |
| Accruals ratio | โ | 2.4% | โ26.8% | โ15.1% | โ14.8% | โ10.7% | โ42.1% | โ21.3% | โ37.3% | โ33.3% |
| Altman Z'' | โ | โ8.42 | โ4.98 | โ0.15 | 1.45 | โ0.57 | โ8.58 | โ6.97 | โ13.43 | โ17.09 |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $113M | $130M | $151M | $210M | $187M | $267M | $299M | $309M | $278M | $233M |
| Net interest income | โ$6.2M | โ$8.2M | โ$3.3M | โ$0.5M | โ$3.0M | โ$12.6M | โ$2.6M | โ$2.3M | โ | โ |
| Research and development | $13.9M | $12.2M | $16.2M | $11.7M | $17.5M | $38.1M | $54.4M | $51.4M | $49.6M | $39.8M |
| Operating income | โ$56.2M | โ$17.1M | โ$40.9M | โ$17.3M | โ$53.9M | โ$123M | โ$458M | โ$136M | โ$195M | โ$102M |
| Interest expense | โ | โ | โ | โ | $3.3M | $12.7M | $4.0M | $6.2M | $8.9M | โ$10.6M |
| Pretax income | โ$75.7M | โ$19.6M | โ$53.0M | โ$17.1M | โ$55.4M | โ$136M | โ$467M | โ$135M | โ$189M | โ$103M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | โ$7.9M | โ$1.4M | $0.0M | $0.0M | $0.0M |
| Net income | โ$75.7M | โ$19.6M | โ$53.0M | โ$17.1M | โ$55.4M | โ$129M | โ$465M | โ$135M | โ$189M | โ$103M |
| Net income to common | โ$76.7M | โ$25.4M | โ$53.2M | โ$17.1M | โ$55.4M | โ$129M | โ$465M | โ$135M | โ | โ |
| Diluted EPS | โ$32.48 | โ$7.86 | โ$2.79 | โ$0.72 | โ$2.04 | โ$3.99 | โ$13.92 | โ$3.69 | โ$3.91 | โ$1.95 |
| Diluted shares | 0.00B | 0.00B | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | 0.04B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | โ$32.5M | โ$22.1M | โ$19.0M | $11.5M | โ$7.6M | โ$38.5M | โ$53.9M | โ$0.2M | โ$8.8M | $9.3M |
| Capital expenditure | $1.8M | $1.2M | $5.9M | $8.3M | $5.4M | $3.1M | $1.2M | $0.7M | $1.6M | $0.5M |
| Free cash flow | โ$34.3M | โ$23.3M | โ$24.9M | $3.2M | โ$13.0M | โ$41.6M | โ$55.1M | โ$0.9M | โ$10.4M | $8.8M |
| Depreciation and amortization | $4.2M | $3.0M | $3.3M | $4.5M | $7.8M | $29.9M | $37.5M | $26.5M | $25.7M | $25.2M |
| Stock-based compensation | $3.4M | $5.1M | $26.8M | $15.9M | $32.4M | $50.3M | $44.7M | $41.0M | $40.4M | $28.1M |
| Acquisitions | โ | โ | โ | $0.0M | $0.0M | $494M | $2.3M | $0.0M | $0.0M | โ |
| Share buybacks | โ | โ | โ | โ | $0.0M | $0.0M | $40.0M | $0.0M | $0.0M | โ |
| Dividends and buybacks | โ | โ | โ | โ | $0.0M | $0.0M | $40.0M | $0.0M | $0.0M | โ |
| Balance sheet | ||||||||||
| Cash and short-term investments | $22.8M | $21.3M | $39.6M | $104M | $293M | $233M | $122M | $91.8M | $65.6M | $48.7M |
| Total debt | โ | $57.0M | $46.7M | $0.0M | $174M | $184M | $226M | $258M | $259M | $209M |
| Finance lease liabilities | โ | โ | โ | โ | $0.0M | โ | โ | โ | โ | โ |
| Current assets | โ | $74.6M | $124M | $196M | $386M | $359M | $250M | $224M | $178M | $137M |
| Current liabilities | โ | $42.1M | $51.9M | $78.4M | $81.3M | $327M | $249M | $171M | $149M | $78.4M |
| Property and equipment, net | โ | $7.3M | $10.2M | $14.3M | $13.9M | $11.3M | $5.9M | $3.3M | $2.6M | $1.9M |
| Goodwill | โ | โ | โ | โ | $0.0M | $743M | $353M | $277M | $159M | $110M |
| Intangible assets | โ | $0.5M | $0.4M | $0.4M | $0.4M | $126M | $53.5M | $35.0M | $11.4M | $5.6M |
| Total assets | โ | $101M | $154M | $224M | $423M | $1.3B | $691M | $574M | $393M | $286M |
| Total liabilities | โ | $309M | $102M | $81.0M | $265M | $573M | $480M | $439M | $323M | $292M |
| Shareholders' equity | โ$217M | โ$209M | $52.0M | $143M | $157M | $691M | $212M | $135M | $70.0M | โ$6.5M |
| Margins | ||||||||||
| Operating margin | โ49.8% | โ13.1% | โ27.2% | โ8.2% | โ28.9% | โ45.9% | โ153.3% | โ43.9% | โ70.2% | โ43.6% |
| EBITDA margin | โ46.1% | โ10.8% | โ25.0% | โ6.1% | โ24.7% | โ34.7% | โ140.8% | โ35.3% | โ61.0% | โ32.8% |
| Net margin | โ67.1% | โ15.1% | โ35.2% | โ8.1% | โ29.7% | โ48.1% | โ155.8% | โ43.6% | โ68.0% | โ44.4% |
| FCF margin | โ30.4% | โ17.9% | โ16.5% | 1.5% | โ7.0% | โ15.6% | โ18.4% | โ0.3% | โ3.7% | 3.8% |
| Net interest share of revenue | โ5.5% | โ6.3% | โ2.2% | โ0.3% | โ1.6% | โ4.7% | โ0.9% | โ0.8% | โ | โ |
| Returns | ||||||||||
| Return on capital | โ | โ | โ54.8% | โ35.2% | โ112.2% | โ15.1% | โ114.5% | โ35.7% | โ58.5% | โ52.3% |
| Return on capital employed | โ | โ29.2% | โ40.2% | โ11.9% | โ15.8% | โ13.1% | โ103.5% | โ33.7% | โ80.2% | โ49.1% |
| Return on equity | โ | โ | โ | โ17.6% | โ36.9% | โ30.3% | โ103.1% | โ77.8% | โ184.9% | โ326.0% |
| Return on assets | โ | โ19.5% | โ41.7% | โ9.1% | โ17.1% | โ15.2% | โ47.6% | โ21.3% | โ39.2% | โ30.5% |
| Return on tangible equity | โ | โ | โ103.1% | โ12.0% | โ35.4% | โ | โ | โ | โ | โ |
| Growth | ||||||||||
| Revenue growth | โ | 15.6% | 15.6% | 39.6% | โ11.2% | 42.9% | 11.8% | 3.6% | โ10.0% | โ16.2% |
| FCF growth | โ | โ | โ | โ | โ509.0% | โ | โ | โ | โ | โ |
| Share count change | โ | 36.8% | 490.1% | 24.6% | 14.6% | 18.3% | 3.8% | 9.2% | 32.5% | 9.8% |
| Financial health | ||||||||||
| Debt / equity | โ | โ | 0.9x | 0.0x | 1.1x | 0.3x | 1.1x | 1.9x | 3.7x | โ |
| Interest coverage | โ | โ | โ | โ | โ16.2x | โ9.7x | โ114.4x | โ21.9x | โ22.0x | โ |
| Current ratio | โ | 1.8x | 2.4x | 2.5x | 4.7x | 1.1x | 1.0x | 1.3x | 1.2x | 1.8x |
| Quick ratio | โ | 1.8x | 2.4x | 2.5x | 4.7x | 1.1x | 1.0x | 1.3x | 1.2x | 1.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.6% | 0.9% | 3.9% | 3.9% | 2.9% | 1.2% | 0.4% | 0.2% | 0.6% | 0.2% |
| Stock comp / revenue | 3.1% | 3.9% | 17.8% | 7.5% | 17.3% | 18.8% | 15.0% | 13.3% | 14.5% | 12.1% |
| Quality scores | ||||||||||
| Piotroski F-score | โ | โ | 3.0 | 5.0 | 2.0 | 3.0 | 2.0 | 4.0 | 2.0 | 5.0 |
| Altman Z'' | โ | โ8.4 | โ5.0 | โ0.2 | 1.4 | โ0.6 | โ8.6 | โ7.0 | โ13.4 | โ17.1 |
| Accruals ratio | โ | 2.4% | โ26.8% | โ15.1% | โ14.8% | โ10.7% | โ42.1% | โ21.3% | โ37.3% | โ33.3% |
Source: SEC EDGAR XBRL filings (CIK 0001666071). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
